Nootropics Market Summary

The global nootropics market size was estimated at USD 3.75 billion in 2022 and is projected to reach USD 11.17 billion by 2030, growing at a compound annual growth rate (CAGR) of 14.6% from 2023 to 2030. The market is expected to expand at a rapid pace over the forecast period, supported by continuous technological advancements and increasing modernization in healthcare, nutrition, and wellness. As awareness surrounding cognitive health rises, consumers are becoming more inclined toward products that enhance memory, focus, creativity, and overall mental performance, further strengthening market demand.

Rising consumer spending on a wide range of healthcare and wellness products is expected to fuel industry growth throughout the forecast period. Consumers are increasingly prioritizing mental well-being and adopting supplements and functional products that support cognitive function. In addition to this shift in lifestyle preferences, the cost-effectiveness of nootropics—combined with their ease of availability across several retail platforms—continues to make them a popular choice for individuals seeking accessible performance-enhancing solutions.

Key Market Trends & Insights

• North America held a major revenue share of over 41.2% of the global nootropics industry in 2022, driven by high consumer awareness and strong product penetration.
• The market in Asia Pacific is anticipated to grow at a CAGR of 15.7% over the forecast period, supported by expanding middle-class populations and growing interest in preventive healthcare.
• Based on distribution channel, the offline channels segment held a 73.7% share in 2022, reflecting strong consumer preference for in-store purchases and expert guidance.
• Based on form, the capsule/tablets segment held a revenue share of 49.2% in the global market in 2022, as these formats offer convenience, dosage accuracy, and widespread acceptance.

Order a free sample PDF of the Nootropics Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2022 Market Size: USD 3.75 Billion
• 2030 Projected Market Size: USD 11.17 Billion
• CAGR (2023-2030): 14.6%
• North America: Largest market in 2022

Key Companies & Market Share Insights

Manufacturers are adopting various strategies to maintain a competitive edge, with a primary focus on introducing a wide variety of nootropics in terms of ingredients, formulations, and delivery methods to cater to different cognitive needs and consumer preferences. Manufacturers are also investing in educating consumers about the benefits and proper usage of nootropics. Some of the initiatives include:

• In September 2022, Neuriva, a cognitive health supplement brand under Reckitt, partnered with chef and food enthusiast Alton Brown to promote a holistic approach to brain health. Through this partnership, Alton Brown aimed to empower consumers to prioritize their brain health as an integral part of their overall well-being. This collaboration highlighted the Neuriva product line, which included Neuriva Plus, along with their new offerings, Neuriva Sleep and Neuriva Brain + Energy.
• In August 2022, Nu: tropic, a UK-based provider of nootropic products, announced the launch of nootropic-based snack bars. The bars are made of Norwegian black oats and include essential brain nutrients such as choline, phosphatidylserine, and omega-3. The bars are available in maple and pecan, salted caramel, raisin and almond, and apple and cinnamon flavors.
• In October 2021, Australia-based start-up Savvy Beverage announced an instant coffee and soda drink containing nootropic ingredients to improve brain function. The product line is an extension of its current product line of functional coffee pods, which are compatible with Nespresso coffee machines.

Key Players

• Onnit Labs, Inc.
• Reckitt Benckiser Group PLC
• Mental Mojo, LLC
• NooCube
• Mind Lab Pro (Performance Lab Group Ltd)
• TruBrain
• Neu Mind, LLC
• Nooflux LLC
• Zhou Nutrition
• Kimera Koffee

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global nootropics market is poised for substantial growth as consumers increasingly prioritize cognitive enhancement, mental clarity, and long-term brain health. With rising awareness of wellness and preventive healthcare, demand for effective and affordable nootropic products continues to accelerate across both developed and emerging markets. The strong presence of offline channels and the widespread adoption of capsule and tablet formats further support industry expansion. North America remains a key revenue contributor, while Asia Pacific is emerging as a fast-growing region. As innovation advances and consumer lifestyles evolve, the nootropics market is expected to maintain strong momentum throughout the coming years.